Coronary Artery Bypass Graft Market Size

  • Report ID: 732
  • Published Date: Nov 28, 2024
  • Report Format: PDF, PPT

Coronary Artery Bypass Graft Market Size

Coronary Artery Bypass Graft Market registered a profitable valuation of USD 14.09 billion in 2024 and is projected to reach USD 44.25 billion by 2037, expanding at a CAGR of 9.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of coronary artery bypass graft is evaluated at USD 15.39 billion.

The primary growth driver of the coronary artery bypass graft market is the rising prevalence of cardiovascular diseases (CVDs) particularly coronary artery disease (CAD). According to the British Heart Foundation, as of 2021, over 250 million people in the world were living with coronary heart disease.

Unhealthy lifestyles, poor dietary habits, smoking, and sedentary behavior have led to a surge in CAD cases, necessitating surgical interventions like coronary artery bypass surgery. Additionally, the growing global elderly population is at higher risk of heart disease, driving demand for CABG procedures. One in six individuals worldwide will be 60 or older by 2030. At this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of individuals in the world who are 60 years of age or older is expected to increase to 2.1 billion by 2050. Between 2020 and 2050, the population of people 80 years of age or older is predicted to triple, reaching 426 million.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 732
  • Published Date: Nov 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global coronary artery bypass graft market registered a valuation of USD 14.09 billion in 2024 and is poised to expand at a CAGR of 9.2% during the forecast period, i.e., 2025-2037.

The global coronary artery bypass graft sector registered a profitable valuation of USD 14.09 billion in 2024 and is poised to register USD 44.25 billion in 2037 expanding at a CAGR of 9.2% during the forecast period, i.e., 2025-2037.

The major players in the market are Guidant Group, MAQUET Holding B.V. & Co.KG, Novadaq Technologies Inc., KARL STORZ GmbH & Co. KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc., and others.

By method, the off-pump segment is poised to register the largest revenue share of 56.2% by 2037. The market growth can be attributed to off-pump CABG’s reduced complications, faster recovery, and advancements in surgical technology.

North America is poised to register the largest revenue share of 49.8% by the end of 2037. The market growth is attributed to the rising prevalence of cardiovascular diseases, particularly CAD.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample